CSF1 and neoplasm: Since the presence of CSF1R+ macrophages within tumors correlates with poor survival in various tumor types, targeting CSF1/CSF1R signaling pathway transduction that promotes tumor growth is an attractive strategy to eliminate TAMs, reduce M2 macrophage recruitment, or repolarize them (43).